Nanophase Technologies (OTCMKTS:NANX – Get Free Report) and Prenetics Global (NASDAQ:PRE – Get Free Report) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.
Institutional & Insider Ownership
70.2% of Nanophase Technologies shares are held by institutional investors. Comparatively, 25.0% of Prenetics Global shares are held by institutional investors. 5.1% of Nanophase Technologies shares are held by company insiders. Comparatively, 7.8% of Prenetics Global shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Risk and Volatility
Nanophase Technologies has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. Comparatively, Prenetics Global has a beta of 0.26, suggesting that its share price is 74% less volatile than the S&P 500.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Nanophase Technologies | 5.59% | 31.49% | 6.67% |
| Prenetics Global | -47.43% | -21.41% | -15.56% |
Analyst Recommendations
This is a summary of current ratings and price targets for Nanophase Technologies and Prenetics Global, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nanophase Technologies | 0 | 0 | 0 | 0 | 0.00 |
| Prenetics Global | 1 | 0 | 4 | 0 | 2.60 |
Prenetics Global has a consensus price target of $34.25, indicating a potential upside of 69.55%. Given Prenetics Global’s stronger consensus rating and higher probable upside, analysts plainly believe Prenetics Global is more favorable than Nanophase Technologies.
Earnings and Valuation
This table compares Nanophase Technologies and Prenetics Global”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nanophase Technologies | $37.30 million | 0.00 | -$4.39 million | $0.05 | N/A |
| Prenetics Global | $154.59 million | 2.20 | -$37.71 million | ($4.16) | -4.86 |
Nanophase Technologies has higher earnings, but lower revenue than Prenetics Global. Prenetics Global is trading at a lower price-to-earnings ratio than Nanophase Technologies, indicating that it is currently the more affordable of the two stocks.
Summary
Nanophase Technologies beats Prenetics Global on 8 of the 13 factors compared between the two stocks.
About Nanophase Technologies
Nanophase Technologies Corporation, a science-driven company, develops, manufactures, and sells integrated family of nanomaterial technologies in the United States. It engages in engineered materials, formulation development, and commercial manufacturing. The company produces engineered nanomaterial products comprising antimony, bismuth, cerium, iron, and zinc oxide for use in a various markets, including surface finishing,exterior coatings, personal care, plastics, scratch resistant coatings, and textiles. It also provides skin care formulations with mineral-based UV protection under the under the Solésence brand; and advanced material products, including architectural coatings, industrial coatings, abrasion-resistant additives, plastics additives, medical diagnostics, and surface finishing technologies applications. The company was incorporated in 1989 and is headquartered in Romeoville, Illinois.
About Prenetics Global
Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.
Receive News & Ratings for Nanophase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanophase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
